Nonribosomal peptides, synthesized by nonribosomal peptide synthetases (NRPS), are an important group of diverse bioactive fungal metabolites. Xylaria sp. BCC1067, which is known to produce a variety of biologically active metabolites, was studied for gene encoding NRPS by two different PCR-based methods and seven different NRPS fragments were obtained. In addition, screening a genomic library with an amplified NRPS fragment as a probe identified a putative NRPS gene named XyNRPSA. The functionality of XyNRPSA for the production of a corresponding metabolite was probed by gene insertion inactivation. Comparing the disrupting metabolite profile with that of the wild type led to the identification of a speculated metabolite. The crude extract of Xylaria sp. BCC1067 also exhibits antifungal activity against the human pathogens Candida albicans and Trichophyton mentagrophytes. However, the evaluation of biological activity of the XyNRPSA product suggests that it is neither a compound with antifungal activity nor a siderophore. In the vicinity of XyNRPSA, a second gene (named XyPtB) was identified. Its localization and homology to orfB of the ergot alkaloid biosynthetic gene cluster suggests that XyPtB may be involved in XyNRPSA product biosynthesis.
Introduction
Nonribosomal peptides (NRPs) are one of the most important groups of fungal secondary metabolites. They have garnered intense interest by virtue of their biotechnological and pharmaceutical applications (Dohren, 2004) . NRPs are biosynthesized by multifunctional nonribosomal peptide synthetases (NRPS), which are characterized by a modular architecture whereby one module harbors all catalytic activities for incorporation of monomers into metabolite products. A module can be further subdivided into several functional domains including adenylation (A), thiolation (T), condensation (C) and optional modification, e.g. epimerization (E) and N-methylation (M), domains (Marahiel et al., 1997) . In the past, corresponding biosynthetic genes have been isolated from a variety of bacteria and fungi, and yielded detailed information on the genetic architecture, domain organization and function of genes involved in the biosynthesis of NRPs in these organisms. Also, considerable interest has developed in the manipulation of the NRPS encoding genes in order to generate novel bioactive compounds through combinatorial biosynthesis (Mootz et al., 2000; Walsh, 2000) . Interestingly, in the case of most known fungal enzymes, the NRPS modules are arranged within a single polypeptide chain (Zocher & Keller, 1997) . Hence, the manipulation of fungal systems has gained much attention due to their potential to generate novel structural compounds. However, to date, knowledge of the genetics of NRPSs in fungi is still very limited; part of the reason is that most fungi producing interesting secondary metabolites are not genetically accessible. However, this is a prerequisite for improving the understanding of the genetic programming of NRPSs in fungi and effective genetic engineering of such systems. Therefore, it seems worthwhile investigating the ability to synthesize novel biologically active compounds in fungi and to perform intensive studies on the molecular biology in these systems. Furthermore, a sufficiently large collection of verified signature sequences for substrate specificity of fungal NRPSs, with special interest in nonproteinogenic amino acids, will offer capabilities for the prediction of the kind of uncharacterized NRPSs produced.
With respect to this, the research was focused on the wood-decay fungus, Xylaria sp. BCC1067, which does have the ability to synthesize a vast variety of secondary metabolites with interesting pharmaceutical properties, like anticancer and antimalarial activities, such as depudecin (polyketide) and 19, 20-epoxycytochalasin Q (hybrid peptide-polyketide) (Isaka et al., 2000) . During the genetic screening for polyketide synthase (PKS) systems in this fungus, several putative PKS and PKS-NRPS hybrid genes have been cloned (Amnuaykanjanasin et al., 2005) . These data imply that this fungal strain may be remarkable for its ability to produce a large variety of unexplored structurally and pharmacologically interesting secondary metabolites, some of which may prove to be useful either for development into commercial drugs or for expanding the repertoire of research tools for combinatorial biosynthesis. Most importantly, Xylaria sp. BCC1067 is genetically accessible and therefore the study of NRPS in this fungus could add an additional dimension to the understanding of the genetic programming of NRP synthesis. Moreover, it could be an attractive model to engineer NRP biosynthesis in fungi.
In this article, two different PCR-based methods for the detection of NRPS genes from Xylaria sp. BCC1067 were described. In addition, the cloning and characterization by gene inactivation of XyNRPSA, a gene that encodes a putative NRPS in Xylaria sp. BCC1067, were reported.
Materials and methods
Fungal strain and culture conditions Xylaria sp. BCC1067 was obtained from the National Center for Genetic Engineering and Biotechnology (BIOTEC) Culture Collection, Thailand. It was maintained at 25 1C on malt extract agar. Malt Extract Broth (Oxoid) was used for nucleic acid isolation and fungal transformation.
PCR detection of NRPS gene fragments
Genomic DNA was extracted as previously described (Reader & Broda, 1985) . Putative NRPS genes were amplified from the Xylaria sp. BCC1067 genomic DNA using various sets of degenerate primers or using degenerate primers in combination with inhibitory primers. Standard PCR reactions (50 mL) contained 50-150 ng of template DNA, 0.5-5 mM each of primers, 200 mM of dNTPs, 1 Â PCR buffer, 1.0-2.5 mM MgCl 2 and 2.5 U Taq DNA polymerase (Promega). The cycling conditions were as follows: 3 min at 94 1C; 30 cycles of 30 s at 94 1C, 30 s at 50-60 1C (according to primer pair melting temperature) and 1 min at 72 1C; and 5 min at 72 1C. PCR products with expected size were purified with a GeneClean-II kit (Bio101) and cloned into pGEM s -T-easy (Promega) for sequencing.
Screening of genomic DNA library
A Xylaria sp. BCC1067 genomic library was using the l-FIXII Cloning Kit (Stratagene). The library was screened with a ( 32 P)-dATP-labeled, using a Prime-A-Gene labeling kit (Promega), amplified NRPS gene fragment from Xylaria sp. BCC1067. Lambda phages with positive hybridization were amplified and the DNA inserts were physically mapped and subcloned into pUC18 for sequencing.
Sequence analysis
The resulting sequences were searched against NCBI's nonredundant database using the BLAST algorithm (Altschul et al., 1997) .
Disruption of XyNRPSA gene
The internal EcoRI fragment, spanning from module 4 to module 5 of XyNRPSA gene, was cloned into pUC18. The resulting plasmid was digested with EcoRV and the internal EcoRV fragment was replaced by a phleomycin-resistant gene cassette (ble), which was excised from the plasmid pOBT (Dr M. Ward, Genecor Inc.) to produce the disruption plasmid pBRL10 (Fig. 3a) . The plasmid was transformed into Xylaria sp. BCC1076 by the methods described by Tilburn et al. (1983) , but with b-glucanase (Glucanex). Phleomycin-resistant transformants carrying a homologous integration of the XyNRPSA gene disruption plasmid were verified by PCR with specific primers: (Fig. 3a) . PCR amplification was performed using the 'Expand long template PCR system' (Roche). The cycling conditions were as follows: 3 min at 94 1C; 30 cycles of 30 s at 94 1C, 45 s at 55 1C and 4 min at 68 1C; and 7 min at 68 1C.
Secondary metabolites analysis
For metabolite profiling, the strains were liquid cultured in a malt-based medium (malt extract 20 g
glucose 20 g L À1 ), and the stationary cultures were incubated at 25 1C. Samples from the supernatant were taken after 21, 28 and 44 days of cultivation. One hundred microliters of unprocessed culture supernatant were filtered through a 0.45 mm filter and applied to HPLC for identification of changes in the secondary metabolite product spectrum. HPLC analysis was performed using an Agilent series 1100 instrument (Agilent, Waldbronn, Germany) with a 250/ 3-Nucleodur-C18 reversed phase column (Macherey-Nagel, Dueren, Germany). UV detection was performed at 214 nm.
Antimicrobial activity assay
Wild type and mutant strains were cultured under growth conditions that led to the identification of the suspected product corresponding to the XyNRPSA gene, which is missing in mutant but present in wild-type strains. The culture filtrates, after 44 days of cultivation, were lyophilized to dryness and then reconstituted with methanol. The crude extracts were evaporated under reduced pressure to obtain a crude extract as a yellow gum. For the assay, the crude extracts were reconstituted with 10% dimethyl sulfoxide (DMSO) to a final concentration of 10% (w/v), sterile by filtration and used for testing against a number of grampositive bacteria (Staphylococcus aureus ATCC29213, Bacillus subtilis ATCC6633), gram-negative bacteria (Escherichia coli ATCC25922, Pseudomonas aeruginosa ATCC27853) and fungi (Candida albicans ATCC10231, clinical isolate Trichophyton mentagrophytes). Antimicrobial activity analyses were measured by the agar diffusion method (Barry, 1991) . Ten percent DMSO was used as a control.
Siderophore production assay
Siderophore production was measured using a modified chrome azurol S (CAS) agar plate assay (Milagres et al., 1999) .
Nucleotide sequence accession numbers
The nucleotide sequences from Xylaria sp. BCC1067 described in this paper have been submitted to the GenBank database. The GenBank accession numbers of the NRPS gene fragments, XyA3(1)-A5, XyA3(2)-T5, XyA3(2)-T9, XyA3(2)-T14, XyA2-A8, XyENC and XyEN11 are DQ486520, DQ486521, DQ486522, DQ486523, DQ486524, DQ486525 and DQ486526, respectively. The GenBank accession number of XyPtB and XyNRPSA are DQ486527 and DQ486528, respectively.
Results and discussion PCR detection of NRPS gene fragments
In a preliminary step, putative NRPS genes were searched in the Xylaria sp. BCC1067 genome using a PCR-based approach with degenerate primers. In this study, multiple sets of degenerate primers were designed to match the highly conserved motifs A3, A5, A6, A7 and T, for adenylation and thiolation domains (Table 1) . Moreover, two degenerate primers corresponding to the conserved motifs A2 and A8 of adenylation domains designed by Neilan et al. (1999) were also used. At least four different products with clear similarity to known NRPSs (named XyA3(1)-A5, XyA3(2)-T5, XyA3(2)-T9 and XyA3(2)-T14) were identified using A3(1)/A5 and A3(2)/T primer pairs. Two degenerate primers (A6 and A7) failed to generate a PCR product even when applied under various amplification conditions. In the case of the A2/A8 primer pair, the PCR product with expected size ($1000 bp) was found to be absent whereas only a short DNA fragment ($640 bp) was generated instead. However, sequence analysis of this PCR fragment (XyA2-A8) revealed homology to known NRPSs and indicated that the A2 primer was not very specific and preferential binds to another annealing site (AGGAYVP) in the genome.
At least five different putative NRPS modules obtained from this fungus may suggest the presence of additional NRPS clusters, although no NRPS gene products have been reported in this strain besides the one hypothesized to be involved in 19, 20-epoxycytochalasin Q biosynthesis. Therefore, it was of concern that investigation of the desired NRPS would be somewhat complicated and the chance to isolate a specific NRPS might be diluted out by the amount of NRPS in the fungus. In order to increase the chance of successful cloning, especially in the case where a whole genome sequence is not available, a sufficiently large collection of a set of NRPS fragments should be generated and serve as probes for identification of entire NRPS gene clusters in the genome.
In this study, Kunihiro's approach was adopted (Kunihiro et al., 2002) to isolate more NRPS genes from Xylaria sp. BCC1067 using the A3(1)/A5 primer pair and the existing XyA3(1)/A5 fragment as a model experiment. This approach involved PCR with a combination of degenerate primers and inhibitory primers of known genes. The addition of inhibitory primers was suggested to overcome the problem in which degenerate primers may tend to amplify a particular gene much more effectively than other genes, making genes with less-conserved sequences at the degenerate primer annealing site difficult to clone. The specific inhibitory primers were designed as described in Fig. 1 . PCR amplification using only the degenerate primer pair, A3(1)/A5, yielded a PCR fragment of the expected size ($400 bp). However, the distinctive fragment of the expected size for the degenerate primer pair disappeared and a new larger band became visible instead, when using the degenerate primer pair in combination with the inhibitory primer pair (data not shown). The sequence analysis of the PCR product indicated that two as-yet undiscovered NRPS fragments, named XyENC and XyEN11, had been successfully cloned, indicating that this technique indeed is applicable as an alternative discovery strategy for obtaining a set of NRPS probes.
The finding of several putative NRPS genes indicated that this fungus may be a potentially rich, but unexplored, source of bioactive peptides. 
Cloning of XyNRPSA gene and adjacent sequence
The XyA3(1)-A5 fragment was randomly chosen for genomic library screening. It is highly similar to biochemically characterized NRPSs such as lysergyl peptide synthetase 1 from Neotyphodium lolii (66% similarity) and peptaibol synthetase from Trichoderma virens (64% similarity). Probing a genomic library followed by a chromosome walking strategy allowed the identification of two overlapping phages that covered an c. 27.5 kb continuous region of the chromosome. Sequence analysis showed that this region contains two potential ORFs, which are transcribed in the opposite direction (Fig. 2a) . The large ORF (20 487 bp), named XyNRPSA, has a high level of homology to known NRPSs. The smaller ORF (1233 bp), named XyPtB, exhibits homologies to hypothetical proteins (Afu6g03450) identified in the Aspergillus fumigatus Af293 genome (45% similarity) and to ergot alkaloid biosynthetic protein B from Claviceps purpurea (46% similarity). Its localization and homology to the orfB of the ergot alkaloid biosynthetic gene cluster (Correia et al., 2003) suggest that XyPtB may be involved in XyNRPSA product biosynthesis. Detailed analysis of XyNRPSA showed that it has a modular organization (AT-CAT-CATE-CAT-CA-CAT-C) with an initiation module (AT), four typical CAT or CATE elongation modules, an incomplete (CA) module and an additional C-domain, not by typical terminal thioesterase (TE)-domain, at the C-terminal end (Fig. 2b) . However, it has been shown that the C-terminal C-domain in fungal NRPSs, probably involved in peptide-chain termination and cyclization, often replaces the TE-domain (Konz & Marahiel, 1999; Keating et al., 2001) . Another interesting feature of XyNRPSA is that it has the incomplete module (C-A bidomain) inserted between the fourth and fifth modules. It is very unusual to find two tandem C-A domains in a single NRPS module. The additional A-domain in the incomplete module may be a requirement for activation of another type of substrate and the activated substrate interaction in trans with the T-domain located in the next module would be possible. Furthermore, the C-domain from the incomplete module lacks the second essential histidine of the core 3 motif Fig. 2 . Organization of the 27.5-kb DNA region and XyNRPSA from Xylaria sp. BCC1067. (a) Schematic map of the 27.5-kb DNA region harboring XyNRPSA (GenBank accession number DQ486528) and XyPtB (GenBank accession number DQ486527) as represented by two overlapping phage clones. The probe, XyA3(1)-A5, obtained by degenerate PCR, is marked. Arrowheads indicate the orientation of the genes and the narrow white boxes denote the putative introns in these genes. The XyNRPSA gene is interrupted by three putative introns of 131, 62 and 59 bp in size, respectively. Sequence analysis of the XyPtB revealed that it was likely to be interrupted by an intron of 105 bp. (b) Modular organization of XyNRPSA. A, adenylation domain; T, thiolation domain; C, condensation domain; E, epimerization domain; M, module. Each A-and C-domain is numbered in order of appearance in the protein starting at the N-terminus. (c) Section of the deduced amino-acid sequence alignment of the six condensation domains of XyNRPSA with the C-domain core region HHxxxDG. Shading indicates amino acids that have been shown to be critical to function by biochemical assay (Stachelhaus et al., 1998; Bergendahl et al., 2002) . Fig. 2c) and is therefore unlikely to be functional. This observation suggests a different mechanism for these modules. On the basis of the modular organization, it seems likely that XyNRPSA is responsible for the production of a penta-or hexapeptide with a D-amino acid within the synthesized peptide. However, to the authors' knowledge, the modular architecture found in XyNRPSA shows no identity to any other NRPS genes in the databases. Hence, it could not be hypothesized for the resulting peptide. The predicted substrate-binding pocket for each of the six A-domains of XyNRPSA (Table 2 ) revealed that they are unique and did not perfectly match any signature sequences, whose specificities were determined experimentally or inferred from the structure of NRPs in the database (Stachelhaus et al., 1999; Challis et al., 2000) . Therefore, the amino-acid specificity of the modules of XyNRPSA could not be definitively predicted. Indeed, the signature sequence of the A-domain from the incomplete module shows significant matches (90%) to the signature sequence for leucine/valine of tex1 from T. virens (Wiest et al., 2002) ( Table 2 ), suggesting that it probably adenylates leucine or valine. In bacteria, prediction of substrate specificity of the A-domain has been partially successful through the use of the signature sequence code. However, this algorithm may not be sufficiently robust to predict substrate specificity of fungal NRPS modules. Part of the reason is that the defined signature sequences from fungi and their specificity may be different from bacterial NRPSs and the experimental information available in fungal NRPS systems is still limited.
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Disruption of XyNRPSA gene
Because the prediction of a putative product was not possible due to bioinformatic methods, targeted gene disruption and identification of changes in the product spectrum were chosen. Disruption of the XyNRPSA gene was performed as described in 'Materials and methods'. Evidence for the XyNRPSA gene disruption through upstream singlecrossover homologous recombination was found in a transformant, named MBz, by PCR amplification with the NRPkn5/Ble1 primer pair. The amplicon of predicted size ($3.6 kb) was confirmed by nested PCR with NRPkn-ext5 (5 0 -GCCAAACGAAAAGCCAACTA-3 0 ) and Ble1 specific primers, to generate a 1353 bp fragment (Fig. 3a and b) .
In order to investigate the corresponding metabolite of XyNRPSA, the resulting mutant was cultivated in the maltbased medium, the same as wild type. The appearance of the metabolites produced by the mutant during growth in liquid culture was subsequently followed by HPLC analysis and compared with that of the wild type. Interestingly, the wild type produced a major peak with a 25.8 min retention time, which increased during the time course of cultivation and displayed maximum intensity after 44 days of culture (Fig. 4a) . Furthermore, the 25.8 min retention time peak was not detected in the mutant through the time course of cultivation (Fig. 4b) . On the basis of these results, it was assumed that the XyNRPSA gene is responsible for the formation of this substance.
Evaluation of biological activity of the XyNRPSA product
The production of antimicrobial activity by the wild type was evaluated against a test panel of bacteria and fungi (see 'Materials and methods'). No antibacterial activity was observed. However, the crude extract of the wild type exhibited potent antifungal activity against human pathogens, C. albicans and T. mentagrophytes with 22 and 14 mm of inhibition zones, respectively. In the mutant, however, no decrease of the inhibition zones compared with the wild type were observed, which indicates that the antifungal activity observed in this case is not caused by the XyNRPSA product but by some other compound(s). On the basis of this given information, it can be expected that a new compound with antifungal activity will be isolated from Xylaria sp. BCC1067 in the future. 
In addition, siderophore production by the wild type and mutant was detected by CAS agar assay. In this assay, the growth rate on the CAS agar plate showed no significant difference between the wild type and mutant. This result leads to the postulation that the XyNRPSA gene may be not involved in siderophore production in this fungus. Moreover, the mutant showed no morphological variations compared with the wild type (data not shown), indicating that the XyNRPSA gene may be not involved in the processes of fungal development.
Information from this study revealed that Xylaria sp. BCC1067 contains a high number of NRPS genes, indicating a strong capacity to produce bioactive metabolites. Further research on NRPSs in this fungus would contribute to the understanding of the genetic programming of NRPSs in fungi and to the identification of interesting peptide metabolites. A4  A6  C6  T   A4  T  A5  C4  A6  C  T C6  C3  A2  A1  T  T  E  C1  A3  C2 , the disruption plasmid; pBRL10 (middle part) and the genomic rearrangement after a successful gene insertion by single homologous crossover in the mutant (lower part) are showed. Plasmid pBRL10 was constructed by cloning the internal 7842 bp EcoRI fragment of XyNRPSA into the EcoRI site of pUC18 and subsequently the internal 4582 bp EcoRV fragment was replaced by phleomycin-resistant gene cassette (ble). The pBRL10 was transformed into Xylaria sp. BCC1067 wild type, and the single-crossover homologous recombination resulted in a genomic rearrangement in the mutant (MBz). The arrows marked with NRPkn5, NRPkn3, Ble1, Ble2 and NRPkn-ext5 represents the primers used to verify the presence of the insertion in the mutant strain using PCR amplification. A, adenylation domain; T, thiolation domain; C, condensation domain; E, epimerization domain; M, module; Ble R , phleomycin-resistant cassette. (b) PCR analysis of the mutant strain. Left panel, amplification of genomic DNA from the mutant (MBz) with NRPkn5/Ble1 primers generated a PCR product of predicted size ($3.6 kb) (lane 1) and NRPkn3/Ble2 primers showed the absence of the predicted PCR fragment (lane2). Right panel, amplification of purified PCR fragment of about 3.6 kb (lane1) and the construct (pBRL10) as positive control (lane2) with NRPkn-ext5/Ble1 primers. The amplicon with purified fragment from the mutant is of the same size ($1.3 kb) as that of the construct. DNA ladder marker (laneM) shows size in kilobases. 
